Brief: HWC Biologics Due To Default Issue, Concluded Financial Statements As Of & For Year Ended Dec 31, 2023 Should Be Restated & No Longer Be Relied Upon
03/05/2024 23:00
May 3 (Reuters) - HCW Biologics Inc HCWB.O :
* HCW BIOLOGICS: DUE TO DEFAULT ISSUE,CONCLUDED FINANCIAL
STATEMENTS AS OF & FOR YEAR ENDED DEC 31, 2023 SHOULD BE
RESTATED & NO LONGER BE RELIED UPON
Source text for Eikon: ID:n0000950170-24-053055
Further company coverage: HCWB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hcw Biologics
See all newsBrief: HCW Biologics Proposed Resale Of Up To 5.69 Million Shares Of Common Stock
Brief: HCW Biologics To Regain Full Rights For Two Commercial-Ready Reagents From Wugen
Brief: HCW Biologics Prices Private Placement Of 2.8 Mln Units At $1.405 Per Unit
NASDAQ RESUMED AT 09:59 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:54 AM